Clinical outcomes according to primary treatment in gastric cancer patients with peritoneal seeding

Journal of Gastric Cancer

Volumn 11, Issue 3, 2011, Pages 167-172

  Bae, Jung Min ^a   Yeo, Kyoung Joon ^a   Kim, Se Won ^a   Kim, Sang Woon ^a   Song, Sun Kyo ^a  

^a Yeungnam University College of Medicine   (South Korea)

Author keywords

Chemotherapy; Gastrectomy; Gastric cancer; Peritoneal seeding

Indexed keywords

EID: 84867495217     PISSN: 2093582X     EISSN: 20935641     Source Type: Journal    
DOI: 10.5230/jgc.2011.11.3.167     Document Type: Review

References (27)

1. Wisbeck WM, Becher EM, Russell AH. Adenocarcinoma of the stomach: autopsy observations with therapeutic implications for the radiation oncologist. Radiother Oncol 1986;7:13-18.
2. Landry J, Tepper JE, Wood WC, Moulton EO, Koerner F, Sullinger J. Patterns of failure following curative resection of gastric carcinoma. Int J Radiat Oncol Biol Phys 1990;19:1357-1362.
3. Gunderson LL, Sosin H. Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 1982;8:1-11.
4. Yonemura Y, Fujimura T, Fushida S, Takegawa S, Kamata T, Katayama K, et al. Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J Surg 1991;15:530-535.
5. Ryu KW, Mok YJ, Kim SJ, Kim CS. Prognostic factors in advanced gastric cancer with peritoneal carcinomatosis. J Korean Surg Soc 2000;59:786-792.
6. Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 1989;63:364-367.
7. Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 2000;88:358-363.
8. Wilke H, Preusser P, Fink U, Gunzer U, Meyer HJ, Meyer J, et al. Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin. J Clin Oncol 1989;7:1318-1326.
9. D'Ugo D, Persiani R, Rausei S, Biondi A, Vigorita V, Boccia S, et al. Response to neoadjuvant chemotherapy and effects of tumor regression in gastric cancer. Eur J Surg Oncol 2006;32:1105-1109.
10. Sugarbaker PH, Yonemura Y. Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure. Oncology 2000;58:96-107.
11. Stern JL, Denman S, Elias EG, Didolkar M, Holyoke ED. Evaluation of palliative resection in advanced carcinoma of the stomach. Surgery 1975;77:291-298.
12. Kim HI, Ha TK, Kwon SJ. Prognostic factors in gastric cancer patients with peritoneal carcinomatosis. J Gastric Cancer 2010;10:126-132.
13. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma-2nd English Edition. Gastric Cancer 1998;1:10-24.
14. Ikeguchi M, Oka A, Tsujitani S, Maeta M, Kaibara N. Relationship between area of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer. Anticancer Res 1994;14:2131-2134.
15. Sugarbaker PH. Peritonectomy procedures. Surg Oncol Clin N Am 2003;12:703-727.
16. Kuramoto M, Shimada S, Ikeshima S, Matsuo A, Yagi Y, Matsuda M, et al. Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma. Ann Surg 2009;250:242-246.
17. Hunerbein M, Rau B, Hohenberger P, Schlag PM. The role of staging laparoscopy for multimodal therapy of gastrointestinal cancer. Surg Endosc 1998;12:921-925.
18. Song SC, Lee SL, Cho YK, Han SU. The role and efficacy of diagnostic laparoscopy to detect the peritoneal recurrence of gastric cancer. J Korean Gastric Cancer Assoc 2009;9:51-56.
19. Shimizu H, Imamura H, Ohta K, Miyazaki Y, Kishimoto T, Fukunaga M, et al. Usefulness of staging laparoscopy for advanced gastric cancer. Surg Today 2010;40:119-124.
20. Yonemura Y, Bandou E, Sawa T, Yoshimitsu Y, Endou Y, Sasaki T, et al. Neoadjuvant treatment of gastric cancer with peritoneal dissemination. Eur J Surg Oncol 2006;32:661-665.
21. Glehen O, Gilly FN, Arvieux C, Cotte E, Boutitie F, Mansvelt B, et al; Association Française de Chirurgie. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 2010;17:2370-2377.
22. Badgwell B, Cormier JN, Krishnan S, Yao J, Staerkel GA, Lupo PJ, et al. Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival? Ann Surg Oncol 2008;15:2684-2691.
23. Hioki M, Gotohda N, Konishi M, Nakagohri T, Takahashi S, Kinoshita T. Predictive factors improving survival aft er gastrectomy in gastric cancer patients with peritoneal carcinomatosis. World J Surg 2010;34:555-562.
24. Kwon SJ. Investigation of long-term survivors with stage IV gastric cancer. J Korean Gastric Cancer Assoc 2002;2:157-162.
25. Seo YJ, Bae JM, Kim SW, Kim SW, Song SK. Diflerent clinical outcomes of stage IV gastric cancer according to the curability of surgery. J Korean Surg Soc 2009;77:170-176.
26. Pollock RE, Roth JA. Cancer-induced immunosuppression: implications for therapy? Semin Surg Oncol 1989;5:414-419.
27. Yoon SY, Kim MG, Oh ST. The impact of preoperative chemotherapy on the surgical management of unresectable gastric cancer. J Korean Gastric Cancer Assoc 2009;9:269-274.